|
Venous Thromboembolism Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 104 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2012" provides data on the Venous Thromboembolism clinical trial scenario. This report prov.....
Introduction GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2012" provides data on the Venous Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous Thromboembolism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Venous Thromboembolism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 7 Introduction 8 Venous Thromboembolism 8 Report Guidance 8 Clinical Trials by Region 9 Clinical Trials by Country 10 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12 Top Five Countries Contributing to Clinical Trials in Europe 13 Top Countries Contributing to Clinical Trials in North America 14 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15 Top Five Countries Contributing to Clinical Trials in Central and South America 16 Clinical Trials by BRIC Nations 17 Clinical Trials by G7 Nations 18 Clinical Trials in G7 Nations by Trial Status 19 Clinical Trials by E7 Nations 20 Clinical Trials in E7 Nations by Trial Status 21 Clinical Trials by Phase 22 In Progress Trials by Phase 23 Clinical Trials by Trial Status 24 Unaccomplished Trials of Venous Thromboembolism 25 Subjects Recruited Over a Period of Time 28 Prominent Sponsors 29 Top Companies Participating in Venous Thromboembolism Therapeutics Clinical Trials 31 Prominent Drug Comparison 33 Clinical Trial Profiles 34 Clinical Trial Overview of Top Companies 34 Bayer AG 34 Clinical Trial Overview of Bayer AG 34 Sanofi 36 Clinical Trial Overview of Sanofi 36 Boehringer Ingelheim GmbH 37 Clinical Trial Overview of Boehringer Ingelheim GmbH 37 Astellas Pharma Inc. 38 Clinical Trial Overview of Astellas Pharma Inc. 38 GlaxoSmithKline plc 39 Clinical Trial Overview of GlaxoSmithKline plc 39 Pfizer Inc. 40 Clinical Trial Overview of Pfizer Inc. 40 AstraZeneca PLC 41 Clinical Trial Overview of AstraZeneca PLC 41 Bristol-Myers Squibb Company 42 Clinical Trial Overview of Bristol-Myers Squibb Company 42 Daiichi Sankyo Company, Limited 43 Clinical Trial Overview of Daiichi Sankyo Company, Limited 43 L.A.L Clinica Pesquisa e Desenvolvimento Ltda. 44 Clinical Trial Overview of L.A.L Clinica Pesquisa e Desenvolvimento Ltda. 44 ThromboGenics NV 45 Clinical Trial Overview of ThromboGenics NV 45 Daiichi Sankyo, Inc. 46 Clinical Trial Overview of Daiichi Sankyo, Inc. 46 Eisai Inc. 47 Clinical Trial Overview of Eisai Inc. 47 LEO Pharma A/S 48 Clinical Trial Overview of LEO Pharma A/S 48 Bayer Inc. 49 Clinical Trial Overview of Bayer Inc. 49 MEDRAD Interventional/POSSIS 50 Clinical Trial Overview of MEDRAD Interventional/POSSIS 50 ARYx Therapeutics, Inc. 51 Clinical Trial Overview of ARYx Therapeutics, Inc. 51 Medco Health Solutions Inc. 52 Clinical Trial Overview of Medco Health Solutions Inc. 52 Novartis AG 53 Clinical Trial Overview of Novartis AG 53 Takeda Pharmaceutical Company Limited 54 Clinical Trial Overview of Takeda Pharmaceutical Company Limited 54 Clinical Trial Overview of Top Universities / Institutes / Hospitals 55 Utrecht University 55 Clinical Trial Overview of Utrecht University 55 Ottawa Hospital Research Institute 56 Clinical Trial Overview of Ottawa Hospital Research Institute 56 University of Calgary 57 Clinical Trial Overview of University of Calgary 57 Centre Hospitalier Universitaire de Saint Etienne 58 Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne 58 The University of Utah 59 Clinical Trial Overview of The University of Utah 59 Brigham and Women's Hospital 60 Clinical Trial Overview of Brigham and Women's Hospital 60 Università degli Studi dell'Insubria 61 Clinical Trial Overview of Università degli Studi dell'Insubria 61 Johann Wolfgang Goethe University Hospitals 62 Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 62 The University of Texas M. D. Anderson Cancer Center 63 Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 63 Hadassah Medical Organization 64 Clinical Trial Overview of Hadassah Medical Organization 64 Hopitaux Universitaires de Geneve 65 Clinical Trial Overview of Hopitaux Universitaires de Geneve 65 Ontario Clinical Oncology Group 66 Clinical Trial Overview of Ontario Clinical Oncology Group 66 Stanford University 67 Clinical Trial Overview of Stanford University 67 University of Padua 68 Clinical Trial Overview of University of Padua 68 St. Joseph's Healthcare Hamilton 69 Clinical Trial Overview of St. Joseph's Healthcare Hamilton 69 St. Orsola Hospital 70 Clinical Trial Overview of St. Orsola Hospital 70 University Hospital, Brest 71 Clinical Trial Overview of University Hospital, Brest 71 Slotervaart Hospital 72 Clinical Trial Overview of Slotervaart Hospital 72 HOPITAL LARIBOISIERE 73 Clinical Trial Overview of HOPITAL LARIBOISIERE 73 University of Missouri 74 Clinical Trial Overview of University of Missouri 74 Five Key Clinical Profiles 75 Appendix 100 Abbreviations 100 Definitions 100 Research Methodology 102 Secondary Research 102 About GlobalData 103 Contact Us 103 Disclaimer 103 Source 104 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9 Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 Venous Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 Venous Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12 Venous Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13 Venous Thromboembolism Therapeutics Clinical Trials, North America, Top Countries, 2012* 14 Venous Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 15 Venous Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16 Venous Thromboembolism Therapeutics Clinical Trials, BRIC Countries, 2012* 17 Venous Thromboembolism Therapeutics Clinical Trials, G7 Countries, 2012* 18 Venous Thromboembolism Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 Venous Thromboembolism Therapeutics Clinical Trials, E7 Countries, 2012* 20 Venous Thromboembolism Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22 Venous Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23 Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 Venous Thromboembolism Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25 Venous Thromboembolism Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26 Venous Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 28 Venous Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 30 Venous Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 32 Venous Thromboembolism Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 34 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 36 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012* 37 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2012* 38 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 39 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 40 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 41 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 42 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2012* 43 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by L.A.L Clinica Pesquisa e Desenvolvimento Ltda., 2012* 44 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by ThromboGenics NV, 2012* 45 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo, Inc., 2012* 46 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 47 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by LEO Pharma A/S, 2012* 48 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer Inc., 2012* 49 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by MEDRAD Interventional/POSSIS, 2012* 50 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by ARYx Therapeutics, Inc., 2012* 51 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Medco Health Solutions Inc., 2012* 52 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 53 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2012* 54 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Utrecht University, 2012* 55 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2012* 56 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2012* 57 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2012* 58 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2012* 59 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2012* 60 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Università degli Studi dell'Insubria, 2012* 61 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2012* 62 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 63 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2012* 64 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2012* 65 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ontario Clinical Oncology Group, 2012* 66 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 67 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Padua, 2012* 68 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Joseph's Healthcare Hamilton, 2012* 69 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Orsola Hospital, 2012* 70 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Brest, 2012* 71 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Slotervaart Hospital, 2012* 72 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by HOPITAL LARIBOISIERE, 2012* 73 Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2012* 74 List of Figures Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9 Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 Venous Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 Venous Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12 Venous Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13 Venous Thromboembolism Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14 Venous Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 15 Venous Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16 Venous Thromboembolism Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17 Venous Thromboembolism Therapeutics Clinical Trials, G7 Countries (%), 2012* 18 Venous Thromboembolism Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 Venous Thromboembolism Therapeutics Clinical Trials, E7 Countries (%), 2012* 20 Venous Thromboembolism Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22 Venous Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23 Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 Venous Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 28 Venous Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29 Venous Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31 Venous Thromboembolism Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33 GlobalData Methodology 102 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
